CBR3 and breast carcinoma: Previously, the effect of carbonyl reductase gene (CBR3-AS1) has been shown in doxorubicin disposition of breast cancer (Xie et al., 2020), but there has been limited number of studies on the role of lcnRNA CBR3-AS1 (21q.22.2) in breast cancer (Zhang et al., 2020).